113 related articles for article (PubMed ID: 8287221)
41. p53 mutations occur in aggressive breast cancer.
Mazars R; Spinardi L; BenCheikh M; Simony-Lafontaine J; Jeanteur P; Theillet C
Cancer Res; 1992 Jul; 52(14):3918-23. PubMed ID: 1617667
[TBL] [Abstract][Full Text] [Related]
42. p53 alterations in uterine leiomyosarcomas versus leiomyomas.
de Vos S; Wilczynski SP; Fleischhacker M; Koeffler P
Gynecol Oncol; 1994 Aug; 54(2):205-8. PubMed ID: 8063247
[TBL] [Abstract][Full Text] [Related]
43. Epidemiological study of p53 tumor suppressor gene mutations in patients from Luxembourg and the German Saar region with an advanced colorectal cancer using PCR-SSCP analysis.
Pauly M; Schmitz M; Kayser I; Lagoda P; Türeci O; Kerschen A; Weber J; Seitz G; Hentges F; Dicato M
Biomed Pharmacother; 1998; 52(5):220-8. PubMed ID: 9755819
[TBL] [Abstract][Full Text] [Related]
44. Analysis of p53 gene mutation by polymerase chain reaction-single strand conformation polymorphism provides independent prognostic information in node-negative breast cancer.
Iacopetta B; Grieu F; Powell B; Soong R; McCaul K; Seshadri R
Clin Cancer Res; 1998 Jul; 4(7):1597-602. PubMed ID: 9676832
[TBL] [Abstract][Full Text] [Related]
45. p53 mutations in nonastrocytic human brain tumors.
Ohgaki H; Eibl RH; Wiestler OD; Yasargil MG; Newcomb EW; Kleihues P
Cancer Res; 1991 Nov; 51(22):6202-5. PubMed ID: 1933879
[TBL] [Abstract][Full Text] [Related]
46. Infrequent mutations in the P53 gene in primary human T-cell acute lymphoblastic leukemia.
Jonveaux P; Berger R
Leukemia; 1991 Oct; 5(10):839-40. PubMed ID: 1961018
[TBL] [Abstract][Full Text] [Related]
47. Aberrations of the CHK2 gene are rare in pediatric solid tumors.
Chen YY; Takita J; Tanaka K; Ida K; Koh K; Igarashi T; Hanada R; Kikuchi A; Tanaka Y; Toyoda Y; Hayashi Y
Int J Mol Med; 2005 Jul; 16(1):85-91. PubMed ID: 15942682
[TBL] [Abstract][Full Text] [Related]
48. Detection of p53 gene mutations in human ovarian and endometrial cancers by polymerase chain reaction-single strand conformation polymorphism analysis.
Naito M; Satake M; Sakai E; Hirano Y; Tsuchida N; Kanzaki H; Ito Y; Mori T
Jpn J Cancer Res; 1992 Oct; 83(10):1030-6. PubMed ID: 1333465
[TBL] [Abstract][Full Text] [Related]
49. Germline mutations of the p53 tumor suppressor gene in children with osteosarcoma.
McIntyre JF; Smith-Sorensen B; Friend SH; Kassell J; Borresen AL; Yan YX; Russo C; Sato J; Barbier N; Miser J
J Clin Oncol; 1994 May; 12(5):925-30. PubMed ID: 8164043
[TBL] [Abstract][Full Text] [Related]
50. Absence of germline and somatic p53 alterations in children with sporadic brain tumors.
Portwine C; Chilton-MacNeill S; Brown C; Sexsmith E; McLaughlin J; Malkin D
J Neurooncol; 2001 May; 52(3):227-35. PubMed ID: 11519852
[TBL] [Abstract][Full Text] [Related]
51. [Assessment of p53 dependent apoptosis in glia-derived tumors of the brain].
Kaczmarczyk R; Słodziński H; Trojanowski T; Polz-Dacewicz M
Neurol Neurochir Pol; 2001; 35 Suppl 5():30-3. PubMed ID: 11935677
[TBL] [Abstract][Full Text] [Related]
52. Prognostic significance of p53 gene alterations in node-negative breast cancer.
Elledge RM; Fuqua SA; Clark GM; Pujol P; Allred DC; McGuire WL
Breast Cancer Res Treat; 1993; 26(3):225-35. PubMed ID: 8251647
[TBL] [Abstract][Full Text] [Related]
53. Frequent p53 gene mutations in soft tissue sarcomas arising in burn scar.
Nakanishi H; Tomita Y; Yoshikawa H; Sato N; Ochi T; Aozasa K
Jpn J Cancer Res; 1999 Mar; 90(3):276-9. PubMed ID: 10359041
[TBL] [Abstract][Full Text] [Related]
54. TP53 mutations in canine brain tumors.
York D; Higgins RJ; LeCouteur RA; Wolfe AN; Grahn R; Olby N; Campbell M; Dickinson PJ
Vet Pathol; 2012 Sep; 49(5):796-801. PubMed ID: 22002975
[TBL] [Abstract][Full Text] [Related]
55. Mutation analysis of p53 gene in childhood malignant solid tumors.
Kusafuka T; Fukuzawa M; Oue T; Komoto Y; Yoneda A; Okada A
J Pediatr Surg; 1997 Aug; 32(8):1175-80. PubMed ID: 9269965
[TBL] [Abstract][Full Text] [Related]
56. How is the mutational status for tumor suppressors p53 and p16(INK4A) in MFH of the bone?
Taubert H; Berger D; Hinze R; Meye A; Würl P; Hogendoorn PC; Holzhausen HJ; Schmidt H; Rath FW
Cancer Lett; 1998 Jan; 123(2):147-51. PubMed ID: 9489481
[TBL] [Abstract][Full Text] [Related]
57. p53 gene mutations in osteosarcomas of low-grade malignancy.
Radig K; Schneider-Stock R; Haeckel C; Neumann W; Roessner A
Hum Pathol; 1998 Nov; 29(11):1310-6. PubMed ID: 9824113
[TBL] [Abstract][Full Text] [Related]
58. An improved method for rapid screening of DNA mutations by nonradioactive single-strand conformation polymorphism procedure.
Chaubert P; Bautista D; Benhattar J
Biotechniques; 1993 Oct; 15(4):586. PubMed ID: 8251155
[No Abstract] [Full Text] [Related]
59. Molecular and immunohistochemical p53 status in liposarcoma and malignant fibrous histiocytoma: identification of seven new mutations for soft tissue sarcomas.
Taubert H; Würl P; Meye A; Berger D; Thamm B; Neumann K; Hinze R; Schmidt H; Rath FW
Cancer; 1995 Oct; 76(7):1187-96. PubMed ID: 8630896
[TBL] [Abstract][Full Text] [Related]
60. Screening for p53 mutations in C3H/He mouse liver tumors derived spontaneously or induced with diethylnitrosamine or phenobarbitone.
Rumsby PC; Davies MJ; Evans JG
Mol Carcinog; 1994 Feb; 9(2):71-5. PubMed ID: 8142011
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
